On 29 May 2026, Kuano brought together speakers and guests at Fora’s Stanley Building in King’s Cross to explore whether agentic approaches can help simulation and AI transform drug discovery.

The afternoon connected perspectives from pharma, enterprise technology, chemistry and investment. Discussions ranged from the challenges of adopting new technologies to the value of specialised scientific models, curated data and automation. A Kuano demo showed how agentic approaches can help orchestrate and scale complex workflows in covalent binder design.

Six panellists seated in front of attendees at Kuano’s King’s Cross event.
Speakers and panellists discussing agentic AI and drug discovery. Image: Kuano.

Thank you to David Barrett, Julian van Velzen, Charlie Harris, Greg Prikler, John Spindler and Ivan Krnić, and to everyone who contributed to the Q&A and conversations afterwards.

Missed the event? Get in touch to continue the conversation or arrange a one-to-one demo.